Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 12039 | 7.77 |
09:34 ET | 3595 | 7.67 |
09:36 ET | 2514 | 7.68 |
09:38 ET | 5933 | 7.73 |
09:39 ET | 400 | 7.74 |
09:41 ET | 469 | 7.74 |
09:43 ET | 1200 | 7.76 |
09:45 ET | 1000 | 7.77 |
09:48 ET | 2798 | 7.77 |
09:50 ET | 200 | 7.765 |
09:52 ET | 3787 | 7.8 |
09:54 ET | 1200 | 7.815 |
09:56 ET | 2417 | 7.855 |
09:57 ET | 300 | 7.865 |
09:59 ET | 900 | 7.87 |
10:01 ET | 4121 | 7.895 |
10:03 ET | 5151 | 7.939 |
10:06 ET | 1600 | 7.96 |
10:08 ET | 5242 | 8.015 |
10:10 ET | 9872 | 7.995 |
10:12 ET | 1960 | 7.995 |
10:14 ET | 1610 | 7.98 |
10:15 ET | 3900 | 7.99 |
10:17 ET | 4628 | 7.98 |
10:19 ET | 1100 | 7.965 |
10:21 ET | 2259 | 7.95 |
10:24 ET | 1365 | 7.95 |
10:26 ET | 2007 | 7.965 |
10:28 ET | 600 | 7.965 |
10:30 ET | 2700 | 7.98 |
10:32 ET | 900 | 7.995 |
10:33 ET | 21386 | 8.025 |
10:35 ET | 21063 | 8.055 |
10:37 ET | 3728 | 8.085 |
10:39 ET | 6291 | 8.085 |
10:42 ET | 10770 | 8.095 |
10:44 ET | 2900 | 8.059 |
10:46 ET | 750 | 8.0507 |
10:48 ET | 2100 | 8.05 |
10:50 ET | 1813 | 8.05 |
10:51 ET | 2976 | 8.035 |
10:53 ET | 1334 | 8.065 |
10:55 ET | 1583 | 8.085 |
10:57 ET | 1800 | 8.05 |
11:00 ET | 1189 | 8.065 |
11:02 ET | 1127 | 8.075 |
11:04 ET | 14341 | 8.075 |
11:06 ET | 1752 | 8.05 |
11:08 ET | 1118 | 8.0557 |
11:09 ET | 700 | 8.05 |
11:11 ET | 3470 | 8.04 |
11:13 ET | 500 | 8.045 |
11:15 ET | 1779 | 8.07 |
11:18 ET | 1901 | 8.04 |
11:20 ET | 3000 | 8.035 |
11:22 ET | 1000 | 8.035 |
11:24 ET | 4369 | 8.04 |
11:26 ET | 5050 | 8.075 |
11:27 ET | 1761 | 8.089 |
11:29 ET | 1200 | 8.08 |
11:31 ET | 1100 | 8.075 |
11:33 ET | 400 | 8.075 |
11:36 ET | 700 | 8.08 |
11:38 ET | 7346 | 8.07 |
11:40 ET | 1300 | 8.06 |
11:42 ET | 1406 | 8.075 |
11:44 ET | 2202 | 8.08 |
11:45 ET | 6619 | 8.1 |
11:47 ET | 100 | 8.11 |
11:49 ET | 1627 | 8.12 |
11:51 ET | 4888 | 8.12 |
11:54 ET | 200 | 8.125 |
11:56 ET | 3495 | 8.135 |
11:58 ET | 300 | 8.145 |
12:00 ET | 1784 | 8.15 |
12:02 ET | 684 | 8.155 |
12:03 ET | 300 | 8.16 |
12:05 ET | 1000 | 8.17 |
12:07 ET | 6276 | 8.18 |
12:09 ET | 2100 | 8.195 |
12:12 ET | 4588 | 8.19 |
12:14 ET | 700 | 8.195 |
12:16 ET | 300 | 8.19 |
12:18 ET | 1696 | 8.19 |
12:20 ET | 2036 | 8.195 |
12:21 ET | 1308 | 8.185 |
12:23 ET | 6428 | 8.21 |
12:25 ET | 3000 | 8.21 |
12:27 ET | 1217 | 8.21 |
12:30 ET | 6099 | 8.19 |
12:32 ET | 1382 | 8.185 |
12:34 ET | 288 | 8.2 |
12:36 ET | 1277 | 8.195 |
12:38 ET | 30807 | 8.2 |
12:39 ET | 4132 | 8.15 |
12:41 ET | 700 | 8.15 |
12:43 ET | 1400 | 8.14 |
12:45 ET | 900 | 8.135 |
12:48 ET | 1500 | 8.12 |
12:50 ET | 108 | 8.125 |
12:52 ET | 4411 | 8.115 |
12:54 ET | 1928 | 8.12 |
12:56 ET | 200 | 8.12 |
12:57 ET | 1402 | 8.13 |
12:59 ET | 700 | 8.155 |
01:01 ET | 1538 | 8.16 |
01:03 ET | 2591 | 8.15 |
01:06 ET | 100 | 8.15 |
01:08 ET | 800 | 8.165 |
01:10 ET | 1698 | 8.16 |
01:12 ET | 3760 | 8.185 |
01:14 ET | 2000 | 8.17 |
01:15 ET | 5561 | 8.1666 |
01:17 ET | 1859 | 8.165 |
01:19 ET | 2568 | 8.16 |
01:21 ET | 1315 | 8.165 |
01:24 ET | 2657 | 8.155 |
01:26 ET | 4547 | 8.165 |
01:28 ET | 6033 | 8.18 |
01:32 ET | 1600 | 8.19 |
01:33 ET | 1713 | 8.185 |
01:35 ET | 1237 | 8.19 |
01:37 ET | 2167 | 8.19 |
01:42 ET | 2764 | 8.175 |
01:44 ET | 7276 | 8.185 |
01:46 ET | 2900 | 8.19 |
01:48 ET | 100 | 8.195 |
01:50 ET | 2074 | 8.205 |
01:51 ET | 4644 | 8.21 |
01:53 ET | 600 | 8.215 |
01:55 ET | 5193 | 8.21 |
01:57 ET | 295 | 8.21 |
02:00 ET | 1700 | 8.195 |
02:02 ET | 1881 | 8.215 |
02:04 ET | 444 | 8.215 |
02:08 ET | 4879 | 8.23 |
02:09 ET | 2081 | 8.225 |
02:11 ET | 8392 | 8.215 |
02:13 ET | 1324 | 8.21 |
02:15 ET | 100 | 8.215 |
02:18 ET | 100 | 8.215 |
02:20 ET | 5635 | 8.18 |
02:22 ET | 4014 | 8.185 |
02:24 ET | 700 | 8.18 |
02:26 ET | 200 | 8.185 |
02:27 ET | 100 | 8.185 |
02:29 ET | 4951 | 8.1899 |
02:31 ET | 3197 | 8.18 |
02:33 ET | 666 | 8.185 |
02:36 ET | 3974 | 8.2 |
02:38 ET | 1448 | 8.205 |
02:40 ET | 3844 | 8.225 |
02:42 ET | 1729 | 8.23 |
02:44 ET | 3652 | 8.225 |
02:45 ET | 500 | 8.22 |
02:47 ET | 1523 | 8.22 |
02:49 ET | 1300 | 8.225 |
02:51 ET | 8381 | 8.235 |
02:54 ET | 1153 | 8.245 |
02:56 ET | 1572 | 8.235 |
02:58 ET | 1327 | 8.24 |
03:00 ET | 2563 | 8.255 |
03:02 ET | 3290 | 8.255 |
03:03 ET | 3927 | 8.255 |
03:05 ET | 5890 | 8.225 |
03:07 ET | 3005 | 8.24 |
03:09 ET | 3493 | 8.245 |
03:12 ET | 1000 | 8.24 |
03:14 ET | 3177 | 8.265 |
03:16 ET | 2657 | 8.26 |
03:18 ET | 100 | 8.255 |
03:20 ET | 2300 | 8.245 |
03:21 ET | 4498 | 8.24 |
03:23 ET | 1145 | 8.245 |
03:25 ET | 1696 | 8.26 |
03:27 ET | 6221 | 8.255 |
03:30 ET | 1584 | 8.27 |
03:32 ET | 2838 | 8.265 |
03:34 ET | 8974 | 8.245 |
03:36 ET | 2500 | 8.24 |
03:38 ET | 1334 | 8.24 |
03:39 ET | 5851 | 8.2299 |
03:41 ET | 4556 | 8.225 |
03:43 ET | 1000 | 8.22 |
03:45 ET | 4251 | 8.215 |
03:48 ET | 3936 | 8.2 |
03:50 ET | 4959 | 8.22 |
03:52 ET | 11342 | 8.21 |
03:54 ET | 9204 | 8.215 |
03:56 ET | 25768 | 8.24 |
03:57 ET | 24128 | 8.25 |
03:59 ET | 270883 | 8.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.0B | -1.8x | --- |
Prothena Corporation PLC | 1.1B | -7.5x | --- |
Immatics NV | 1.0B | -7.8x | --- |
Arcutis Biotherapeutics Inc | 987.4M | -2.2x | --- |
SAGE Therapeutics Inc | 816.2M | -1.6x | --- |
Regenxbio Inc | 787.6M | -2.7x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
---|---|
Revenue (TTM) | $86.2M |
Shares Outstanding | 135.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-4.59 |
Book Value | $11.80 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 12.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -794.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.